IGF-1 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-02. Numbers and descriptions here follow the published literature rather than marketing material.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue peptide | GHRH analog backbone |
| Approximate molecular mass | 5136 Da | Varies with counterion and hydration state |
| N-terminal group | trans-3-hexenoyl | Increases resistance to dipeptidyl peptidase IV |
| Primary receptor | GHRH receptor (GHRHR) | Class B G protein-coupled receptor on somatotrophs |
| Principal mediator | IGF-1 | Rises indirectly after growth hormone release |
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
=== ER-Retention Signal === In eukaryotes, most of the newly synthesized secretory proteins are transported from the ER to the Golgi apparatus. If these proteins have a particular 4-amino-acid retention sequence for the ER's lumen, KDEL, on their C-terminus, they are retained in the ER's lumen or are routed back to the ER's lumen (in instances where they escape) via interaction with the KDEL receptor in the Golgi apparatus. If the signal is KKXX, the retention mechanism to the ER will be similar but the protein will be transmembranal.
This stratified squamous epithelium is maintained by cell division within the stratum basale, in which differentiating cells slowly displace outwards through the stratum spinosum to the stratum corneum, where cells are continually shed from the surface. In normal skin, the rate of production equals the rate of loss; about two weeks are needed for a cell to migrate from the basal cell layer to the top of the granular cell layer, and an additional two weeks to cross the stratum corneum. The dermis is the layer of skin between the epidermis and subcutaneous tissue, and comprises two sections, the papillary dermis and the reticular dermis. The superficial papillary dermis interdigitates with the overlying rete ridges of the epidermis, between which the two layers interact through the basement membrane zone. Structural components of the dermis are collagen, elastic fibers, and ground substance. Within these components are the pilosebaceous units, arrector pili muscles, and the eccrine and apocrine glands. The dermis contains two vascular networks that run parallel to the skin surface—one superficial and one deep plexus—which are connected by vertical communicating vessels. The function of blood vessels within the dermis is fourfold: to supply nutrition, to regulate temperature, to modulate inflammation, and to participate in wound healing. The subcutaneous tissue is a layer of fat between the dermis and underlying fascia.
== Description == Acid dyes are generally divided into three classes according to their fastness requirements, migration ability, and dyeing pH. Acid dyes affix to fibers by hydrogen bonding, Van der Waals forces and ionic bonding. While some acid dyes work in water, many choose to activate dyes in acid dye-baths instead. According to the Brønsted–Lowry acid–base theory, an acid is a molecule or ion capable of donating a proton, and this is determined by the acid dissociation constant. Compared to most acids, water has a much higher pKa value, meaning that it dissociates to give H+ with more difficulty. In this context, if an acid is used instead of water, then the hydrogen ion (H+) is more easily able to dissociate in order to react with the aniline dye anion, allowing the dye to dissolve. Animal protein fibers and the synthetic fiber nylon contain many cationic sites that bind anionic dye. The strength (fastness) of this bond reflects the strength of this ionic interaction.
== Statement on the Generic Masculine in the German Language (2022) == In 2022 in the weekly newspaper Die Zeit, Kermani presented his view on the use of the generic masculine from a writer’s perspective. In this essay, Kermani notes that German is the only language “from which the gender-neutral use of masculine nouns and pronouns could disappear entirely.” He deeply regrets this possible development. After all, the generic masculine “allows for a great deal of linguistic differentiation,” whereas its abolition would promote the sexualization of language and “would not advance gender equality one bit.” As an example, Kermani mentions that German female authors who did not wish to explicitly emphasize their gender still naturally referred to themselves as “Autoren” as recently as the 1970s. But now, the generic masculine is on the decline and is often no longer understood: “No matter how often a linguist may point out that a word like ‘reader’ (‘Leser’)is a generic term and that, strictly speaking, one should say ‘male readers’ when referring exclusively to men—as soon as no one hears female readers implied in the word ‘reader’ anymore, the scholar is, at best, correct only from a historical linguistic perspective.” – Navid Kermani: Mann, Frau, völlig egal [Man, Woman, It Doesn’t Matter at All] According to Kermani, the unique stylistic achievement of the generic masculine is that it does a good job of doing justice to “the diverse transitions, overlaps, and ambivalences” that define what it means to be human.
=== Federal regulation === Laboratory testing in the United States is subject to federal regulation. Clinical laboratories performing testing are overseen by the Centers for Medicare and Medicaid Services (CMS) utilizing national standards established under the Clinical Laboratory Improvement Amendments (CLIA). The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) assist CMS in this process.
Sources: en.wikipedia.org
PKS, carbon-carbon bond formation through Claisen condensation reaction NRPs, the C domain catalyzes the amide bond formation between the amino acid it adds to the chain (on the PCP of one module) and the nascent peptide (on the PCP of the next module).
In 1955, Soviet paleontologist Evgeny Maleev named a new species, Tyrannosaurus bataar, from Mongolia. By 1965, this species was renamed as a distinct genus, Tarbosaurus bataar. While most paleontologists continue to maintain the two as distinct genera, some authors such as Thomas Holtz, Kenneth Carpenter, and Thomas Carr argue that the two species are similar enough to be considered members of the same genus, restoring the Mongolian taxon's original binomial name. Some specimens from the Late Cretaceous deposits of China have been described as new species of Tyrannosaurus: T. "lanpingensis" based on isolated lateral tooth from the red beds of Yunnan in 1975; T. "turpanensis" from the Subashi Formation, Turpan Basin, Xinjiang in 1978; and T. luanchuanensis from the Quiba Formation in Henan Province in 1979–1980. The former two taxa were published without detailed descriptions and are therefore nomina nuda. T. "turpanensis" and T. luanchuanensis were tentatively listed as junior synonyms of Tarbosaurus bataar by Holtz in 2004; Holtz also listed T. "lanpingensis," but as a nomen dubium. VGI, no. 231/3, a large phalanx bone, assigned to Tyrannosaurus sp. by Yarkov in 2000, was found in the Lower Maastrichtian of Bereslavka, Russia. In 2004, Averianov and Yarkov reinterpreted it as a metacarpal or metatarsal that possibly belongs to ceratosaur. In their 2023 overview, Averianov and Lopatin mention this specimen as well as a single tooth from the same site only as Theropoda indet.
=== Cystinosis === Mutations in CTNS gene can result in cystinosis. Cystinosis is a type of lysosomal transport disorder, a subset of lysosomal storage disorders. Variation in the encoded cystinosin protein results in an inhibition or loss in its ability to transport cystine out of the lysosome. Cystine molecules accumulate and form crystals within the lysosome, impairing its function.
Between 73 and 71 BCE the Third Servile War was fought, during which the Thracian gladiator Spartacus gathered around him tens of thousands of desperate slaves, including many Bruttians, and set out northward from Capua, defeating many Roman legions. But the intervention of Marcus Licinius Crassus in a battle on the Sele River in Campania crushed any claim of Spartacus and his men. 6,000 slaves were crucified along the Appian Way. Magna Graecia is commemorated by Marcus Tullius Cicero in a 44 BCE letter written from Calabria. He was traveling to Greece in the confusing situation after Caesar's assassination on the Ides of March.
Sources: en.wikipedia.org
Malic acid is typically associated with the taste of green apples, while lactic acid is richer and more buttery tasting. Grapes produced in cool regions tend to be high in acidity, much of which comes from the contribution of malic acid. Malolactic fermentation generally enhances the body and flavor persistence of wine, producing wines of greater palate softness. Many winemakers also feel that better integration of fruit and oak character can be achieved if malolactic fermentation occurs during the time the wine is in barrel. A wine undergoing malolactic conversion will be cloudy because of the presence of bacteria, and may have the smell of buttered popcorn, the result of the production of diacetyl. The onset of malolactic fermentation in the bottle is usually considered a wine fault, as the wine will appear to the consumer to still be fermenting (as a result of CO2 being produced). However, for early Vinho Verde production, this slight effervesce was considered a distinguishing trait, though Portuguese wine producers had to market the wine in opaque bottles because of the increase in turbidity and sediment that the "in-bottle MLF" produced. Today, most Vinho Verde producers no longer follow this practice and instead complete malolactic fermentation prior to bottling with the slight sparkle being added by artificial carbonation.
=== Teaser tracks on social media === A video of Williams dancing to a song from the album was posted to Instagram by Gabriel Moses in August 2024. Pusha T posted a video to his Instagram account on May 7, 2025, captioned with the song title "So Far Ahead". The video, serving as a trailer for the song, featured footage of him getting ready for the 2025 edition of the Met Gala, spliced with images of figures like slave William Lee, boxer and activist Muhammad Ali, and artist Jean-Michel Basquiat. "So Be It" was previewed on Instagram Live by DJ Hed, and on radio station Hot 97 by disc jockey Funkmaster Flex, both on June 16, a day before the song's official release as a music video. Athlete LeBron James took to Instagram on June 23 to preview Nas' guest verse on "Let God Sort Em Out / Chandeliers."
Amyloid beta can be measured semiquantitatively with immunostaining, which also allows one to determine location. Amyloid beta may be primarily vascular, as in cerebral amyloid angiopathy, or in amyloid plaques in white matter. One sensitive method is ELISA which is an immunosorbent assay which utilizes a pair of antibodies that recognize amyloid beta. Atomic force microscopy, which can visualize nanoscale molecular surfaces, can be used to determine the aggregation state of amyloid beta in vitro. Vibrational microspectroscopy is a label-free method that measures the vibration of molecules in tissue samples. Amyloid proteins like Aβ can be detected with this technique because of their high content of β-sheet structures. Dual polarisation interferometry is an optical technique which can measure early stages of aggregation by measuring the molecular size and densities as the fibrils elongate. These aggregate processes can also be studied on lipid bilayer constructs. TPM21 Sylvain Lesné – Aβ*56 Online Mendelian Inheritance in Man (OMIM): 104300
Radiation Source Use and Replacement: Abbreviated Version. National Academies Press. ISBN 978-0-309-11014-3. O'Neil, Marydale J.; Heckelman, Patricia E.; Roman, Cherie B., eds. (2006). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (14th ed.). Merck Research Laboratories, Merck & Co. ISBN 978-0-911910-00-1. Osborne-Lee, I. W.; Alexander, C. W. (1995). "Californium-252: A Remarkable Versatile Radioisotope". Oak Ridge Technical Report ORNL/TM-12706. doi:10.2172/205871. OSTI 205871. Ruiz-Lapuente, P.; Canal, R.; Isern, J. (1996). Thermonuclear Supernovae. Springer Science+Business Media. ISBN 978-0-7923-4359-2. Seaborg, Glenn T.; Loveland, Walter D. (1990). The Elements Beyond Uranium. John Wiley & Sons, Inc. ISBN 978-0-471-89062-1. Seaborg, Glenn T. (1994). Modern alchemy: selected papers of Glenn T. Seaborg. World Scientific. ISBN 978-981-02-1440-1. Seaborg, Glenn T. (1996). Adloff, J. P. (ed.). One Hundred Years after the Discovery of Radioactivity. Oldenbourg Wissenschaftsverlag. ISBN 978-3-486-64252-0. Seaborg, Glenn T. (2004). "Californium". In Geller, Elizabeth (ed.). Concise Encyclopedia of Chemistry. McGraw-Hill. p. 94. ISBN 978-0-07-143953-4. Szwacki, Nevill Gonzalez; Szwacka, Teresa (2010). Basic Elements of Crystallography. Pan Stanford. ISBN 978-981-4241-59-5. Walker, Perrin; Tarn, William H., eds. (1991). Handbook of Metal Etchants. CRC Press. ISBN 978-0-8493-3623-2. Weeks, Mary Elvira; Leichester, Henry M. (1968). "21: Modern Alchemy". Discovery of the Elements. Journal of Chemical Education. pp. 848–850. ISBN 978-0-7661-3872-8.
==== United States ==== In March 2020, the FDA changed the regulatory pathway for approval of new insulin products. Insulin is regulated as a biologic rather than as a drug. The changed status gives the FDA more flexibility for approval and labeling. In July 2021, the FDA approved insulin glargine-yfgn (Semglee), a biosimilar product that contains the long acting analog insulin glargine. Insulin glargine-yfgn is interchangeable and less expensive than the reference product, insulin glargine (Lantus), which had been approved in 2000. The FDA requires that new insulin products are not inferior to existing insulin products with respect to reduction in hemoglobin A1c.
Sources: en.wikipedia.org
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.
Growth hormone released from the pituitary stimulates IGF-1 production in the liver and other tissues, so circulating IGF-1 generally rises during exposure. The size of the rise varies between individuals and depends on baseline hormonal status and other concurrent factors.
Reported imaging studies focus on visceral adipose tissue, where reductions are more consistently observed across trials. Subcutaneous depots show smaller and less reproducible changes, so the two compartments should not be treated as equivalent.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.